Testing the DNA Damage Response as a Driver of Aging
This commentary examines the idea that persistent activation of the DNA damage response may be a key upstream driver of aging. It proposes that chronic engagement of tumor-suppressor pathways can promote senescence, stem-cell loss, and inflammation, a concept called the guardian paradox. The author outlines 16 candidate axes and suggests longitudinal, mediation, and head-to-head tests to compare this model with mitochondria-, proteostasis-, and reprogramming-first explanations.
The commentary proposes that persistent DNA damage response activity, even without mutations, may act as an upstream aging node. It argues this can dysregulate intact tumor-suppressor and related guardian networks, leading to senescence, stem-cell depletion, and inflammaging. The author calls this tension the guardian paradox.
In cancer, mutations often disable these guardians; in aging, wild-type pathways may be chronically overactive (p53, p16INK4a) or silenced through epigenetic changes (SIRT1, FOXO3, NRF2, Klotho). The piece maps 16 candidate axes across three evidence tiers and contrasts the model with mitochondria-, proteostasis-, and reprogramming-first explanations. It proposes longitudinal, mediation, and head-to-head tests, while noting no integrated human interventional data exist.
If validated, this framework could influence how researchers prioritize aging interventions, potentially shifting attention toward modulating DNA damage response pathways rather than only mitochondria, proteostasis, or reprogramming. People affected may include older adults and those at risk of age-related decline, though benefits would depend on future clinical translation. Because the paper offers a research agenda rather than a protocol, near-term societal impact may be limited to scientific direction, funding priorities, and public discussion about aging biology.